What You Need to Know About PAH and Scleroderma

Recent Posts

• Pulmonary hypertension may be scleroderma marker of prognosis
• Scleroderma community gears up for awareness month in June
• Heart fibrosis may contribute to sudden death in systemic sclerosis
• Ofev consistently slows lung function decline in SSc-ILD: Study
• Large study IDs risks for primary heart involvement in scleroderma
• Age, sex, socioeconomics tied to localized scleroderma risk: Study
• Why those of us with scleroderma need patient-centered care
• Sex differences confirmed in SSc, with 5 times higher risk for women
• Exosome-based therapy eases skin scarring in scleroderma mice: Study
• ALLO-329 gets FDA fast track designation for diffuse scleroderma